Overview
Nyxoah S.A. is a Belgium-based health technology company that primarily operates in the medical device industry. The company's key focus is on developing innovative and effective solutions to treat Obstructive Sleep Apnea (OSA), a condition that affects millions of people worldwide. Nyxoah's flagship project is the Genio® system, a battery-free, minimally invasive solution for OSA.
Quality, Value, Momentum Scores
This card shows the Quality, Value, and Momentum scores for the company
Income Statement: Revenue, Operating Income, Net Income
- The revenue for Nyxoah SA as of 30 June 2025 is 4.93 MM.
- The operating income for Nyxoah SA as of 30 June 2025 is -73.78 MM.
- The net income for Nyxoah SA as of 30 June 2025 is -77.20 MM.
Period End (TTM) | Revenue (MM) | Operating Income (MM) | Net Income (MM) |
2025-06-30 | 4.93 | -73.78 | -77.20 |
2025-03-31 | 4.36 | -67.23 | -69.71 |
2024-12-31 | 4.52 | -58.81 | -59.24 |
2024-09-30 | 5.08 | -51.34 | -52.98 |
2024-06-30 | 4.79 | -47.34 | -43.53 |
2024-03-31 | 5.13 | -45.92 | -43.21 |
2023-12-31 | 4.35 | -45.10 | -43.21 |
2023-09-30 | 3.83 | -43.31 | -45.62 |
2023-06-30 | 3.04 | -41.11 | -44.24 |
2023-03-31 | 2.87 | -36.61 | -36.44 |
2022-12-31 | 3.08 | -32.50 | -31.23 |
2022-09-30 | 2.07 | -29.99 | -24.18 |
2022-06-30 | 2.09 | -29.29 | -26.70 |
2022-03-31 | 1.33 | -28.20 | -28.65 |
2021-12-31 | 0.85 | -26.24 | -27.62 |
2021-09-30 | 0.59 | -23.34 | -25.34 |
2021-06-30 | 0.42 | -18.91 | -20.55 |
2021-03-31 | 0.25 | -14.50 | -15.53 |
2020-12-31 | 0.07 | -11.22 | -12.24 |
2020-09-30 | 0.03 | -9.85 | -10.72 |
2020-06-30 | |||
2020-03-31 |
Income Statement: EPS
Period End (TTM) | Earnings Per Share Basic | Earnings Per Share Diluted |
2025-06-30 | ||
2025-03-31 | ||
2024-12-31 | -1.81 | -1.81 |
2024-09-30 | -1.73 | -1.73 |
2024-06-30 | -1.49 | -1.49 |
2024-03-31 | -1.51 | -1.51 |
2023-12-31 | -1.55 | -1.54 |
2023-09-30 | -1.67 | -1.67 |
2023-06-30 | -1.67 | -1.67 |
2023-03-31 | -1.41 | -1.41 |
2022-12-31 | -1.21 | -1.21 |
2022-09-30 | -0.94 | -0.94 |
2022-06-30 | -1.04 | -1.04 |
2022-03-31 | -1.16 | -1.16 |
2021-12-31 | -1.16 | -1.16 |
2021-09-30 | -1.14 | -1.14 |
2021-06-30 | -0.98 | -0.98 |
2021-03-31 | -0.79 | -0.79 |
2020-12-31 | -0.68 | -0.68 |
2020-09-30 | -0.38 | -0.38 |
2020-06-30 | -0.61 | -0.61 |
2020-03-31 | -0.64 | -0.64 |
Cash Flow: Operations, Investing, Financing
- The cash from operating activities for Nyxoah SA as of 30 June 2025 is -60.89 MM.
- The cash from investing activities for Nyxoah SA as of 30 June 2025 is 26.02 MM.
- The cash from financing activities for Nyxoah SA as of 30 June 2025 is 31.26 MM.
Period End (TTM) | Cash From Operating Activities (MM) | Cash From Investing Activities (MM) | Cash From Financing Activities (MM) |
2025-06-30 | -60.89 | 26.02 | 31.26 |
2025-03-31 | -55.47 | -20.83 | 76.96 |
2024-12-31 | -49.23 | -16.32 | 77.44 |
2024-09-30 | -48.71 | 11.02 | 53.35 |
2024-06-30 | -45.89 | 12.56 | 44.04 |
2024-03-31 | -46.39 | 33.28 | 1.22 |
2023-12-31 | -44.78 | 32.01 | 16.86 |
2023-09-30 | -43.47 | -47.05 | 17.36 |
2023-06-30 | -41.51 | -34.08 | 17.18 |
2023-03-31 | -33.93 | -31.01 | 14.55 |
2022-12-31 | -28.76 | -89.95 | -0.98 |
2022-09-30 | -25.72 | -34.99 | 0.67 |
2022-06-30 | -26.71 | -59.28 | 76.40 |
2022-03-31 | -26.67 | -57.61 | 76.43 |
2021-12-31 | -25.34 | -11.82 | 76.47 |
2021-09-30 | -19.43 | -11.99 | 114.19 |
2021-06-30 | -11.20 | -11.56 | 78.01 |
2021-03-31 | -9.98 | -10.69 | 79.23 |
2020-12-31 | -6.86 | -10.69 | 104.03 |
2020-09-30 | -6.88 | -9.03 | 65.31 |
2020-06-30 | |||
2020-03-31 |
Valuation Metrics : PE, PriceToBook, PriceToTBV
- The p/e for Nyxoah SA as of 30 June 2025 is -3.47.
- The p/book for Nyxoah SA as of 30 June 2025 is 2.61.
- The p/tbv for Nyxoah SA as of 30 June 2025 is 2.62.
- P/Book
- The current closing price divided by the book value per share.
- P/TBV
- The current price divided by the tangible book value per share.
Period End (TTM) | p/e | P/Book | P/TBV |
2025-06-30 | -3.47 | 2.61 | 2.62 |
2025-03-31 | -4.47 | 2.34 | 4.21 |
2024-12-31 | -5.72 | 2.89 | 2.90 |
2024-09-30 | -6.60 | 2.39 | 2.40 |
2024-06-30 | -5.23 | 2.59 | 2.61 |
2024-03-31 | -8.20 | 3.61 | 6.89 |
2023-12-31 | -2.72 | 1.14 | 1.15 |
2023-09-30 | |||
2023-06-30 | |||
2023-03-31 | |||
2022-12-31 | |||
2022-09-30 | |||
2022-06-30 | |||
2022-03-31 | -16.48 | 3.06 | 3.07 |
2021-12-31 | -23.32 | 5.63 | 5.67 |
2021-09-30 | -30.79 | 7.43 | 7.49 |
2021-06-30 | -6.69 | 1.61 | 1.63 |
2021-03-31 | -8.82 | 1.50 | 1.51 |
2020-12-31 | -11.19 | 1.41 | 1.42 |
2020-09-30 | -12.97 | 1.41 | 1.42 |
2020-06-30 | |||
2020-03-31 |
Valuation Metrics : EBitToEv, EBit3YrAvgToEv
- The ebit/ev for Nyxoah SA as of 30 June 2025 is -0.28.
- The ebit (3y)/ev for Nyxoah SA as of 30 June 2025 is -0.22.
Period End (TTM) | EBIT/EV | EBIT (3y)/EV |
2025-06-30 | -0.28 | -0.22 |
2025-03-31 | -0.23 | -0.18 |
2024-12-31 | -0.18 | -0.14 |
2024-09-30 | -0.17 | -0.14 |
2024-06-30 | -0.21 | -0.17 |
2024-03-31 | -0.13 | -0.10 |
2023-12-31 | -0.38 | -0.26 |
2023-09-30 | -0.22 | -0.15 |
2023-06-30 | -0.20 | -0.15 |
2023-03-31 | -0.18 | -0.14 |
2022-12-31 | -0.41 | -0.37 |
2022-09-30 | -0.23 | -0.18 |
2022-06-30 | -0.14 | -0.10 |
2022-03-31 | -0.08 | -0.05 |
2021-12-31 | -0.05 | -0.03 |
2021-09-30 | -0.04 | -0.02 |
2021-06-30 | -0.31 | -0.19 |
2021-03-31 | -0.26 | -0.19 |
2020-12-31 | -0.23 | -0.18 |
2020-09-30 | -0.19 | -0.06 |
2020-06-30 | ||
2020-03-31 |
Management Effectiveness
- The roa for Nyxoah SA as of 30 June 2025 is -0.47.
- The roe for Nyxoah SA as of 30 June 2025 is -0.64.
- The roic for Nyxoah SA as of 30 June 2025 is -0.61.
- The croic for Nyxoah SA as of 30 June 2025 is 0.00.
- The ocroic for Nyxoah SA as of 30 June 2025 is -0.48.
Period End (TTM) | ROA | ROE | ROIC | CROIC | OCROIC |
2025-06-30 | -0.47 | -0.64 | -0.61 | 0.00 | -0.48 |
2025-03-31 | -0.52 | -0.80 | -0.44 | 0.09 | -0.36 |
2024-12-31 | -0.43 | -0.60 | -0.41 | 0.12 | -0.38 |
2024-09-30 | -0.39 | -0.49 | -0.33 | 0.08 | -0.35 |
2024-06-30 | -0.29 | -0.35 | -0.43 | -0.12 | -0.46 |
2024-03-31 | -0.30 | -0.36 | -0.39 | -0.69 | -0.39 |
2023-12-31 | -0.28 | -0.34 | -0.38 | -0.63 | -0.36 |
2023-09-30 | -0.27 | -0.32 | -0.34 | -0.46 | -0.32 |
2023-06-30 | -0.22 | -0.32 | -0.34 | -0.46 | -0.32 |
2023-03-31 | -0.19 | -0.26 | -0.27 | -0.36 | -0.25 |
2022-12-31 | -0.22 | -0.28 | -0.17 | -0.35 | -0.18 |
2022-09-30 | -0.16 | -0.16 | -0.17 | -0.35 | -0.18 |
2022-06-30 | -0.26 | -0.31 | -0.18 | -0.02 | -0.18 |
2022-03-31 | -0.25 | -0.31 | -0.19 | -0.02 | -0.17 |
2021-12-31 | -0.18 | -0.28 | -0.17 | 0.27 | -0.12 |
2021-09-30 | -0.21 | -0.25 | -0.15 | 0.52 | -0.12 |
2021-06-30 | -0.54 | -0.81 | -0.21 | 0.57 | -0.12 |
2021-03-31 | -1.02 | -6.58 | -0.15 | 0.57 | -0.10 |
2020-12-31 | -0.81 | -5.19 | -0.11 | 0.79 | -0.06 |
2020-09-30 | -0.69 | -4.47 | -0.10 | 0.45 | -0.06 |
2020-06-30 | -0.51 | -0.88 | -0.27 | 0.36 | -0.20 |
2020-03-31 | -0.50 | -0.87 | -0.83 | 1.25 | -0.52 |
Gross Margins
- The gross margin for Nyxoah SA as of 30 June 2025 is 0.66.
- The net margin for Nyxoah SA as of 30 June 2025 is -15.97.
- The operating margin for Nyxoah SA as of 30 June 2025 is -15.41.
- Gross Margin
- The Gross Margin is the ratio of revenue left after substracting the Cost of Goods Sold. It is calculated as 1.0 - (Revenue - COGS ) / Revenue.
- Net Margin
- The Net Margin (aka Profit Margin) is the ratio of revenue left after substracting the Net Income. It is calculated as Net Income / Revenue.
- Operating Margin
- The Operaing Margin is the ratio of revenue left after substracting the Operating Income. It is calculated as Operating Income / Revenue.
Period End (TTM) | Gross Margin | Net Margin | Operating Margin |
2025-06-30 | 0.66 | -15.97 | -15.41 |
2025-03-31 | 0.66 | -13.10 | -13.01 |
2024-12-31 | 0.62 | -10.43 | -10.10 |
2024-09-30 | 0.62 | -9.08 | -9.88 |
2024-06-30 | 0.62 | -8.43 | -8.95 |
2024-03-31 | 0.62 | -9.94 | -10.37 |
2023-12-31 | 0.64 | -11.91 | -11.31 |
2023-09-30 | 0.63 | -14.57 | -13.54 |
2023-06-30 | 0.64 | -14.57 | -13.54 |
2023-03-31 | 0.63 | -12.72 | -12.78 |
2022-12-31 | -2.19 | -11.67 | -14.47 |
2022-09-30 | -2.17 | -11.67 | -14.47 |
2022-06-30 | -3.79 | -12.76 | -14.00 |
2022-03-31 | -6.19 | -21.59 | -21.25 |
2021-12-31 | -6.97 | -32.42 | -30.80 |
2021-09-30 | -6.97 | -40.72 | -39.46 |
2021-06-30 | -6.97 | -48.47 | -44.60 |
2021-03-31 | -7.35 | -61.16 | -57.07 |
2020-12-31 | -7.88 | -177.46 | -162.67 |
2020-09-30 | -18.09 | -305.74 | -280.51 |
2020-06-30 | |||
2020-03-31 |
Identifiers and Descriptors
Central Index Key (CIK) | 1857190 |
Industry Groups
SIC 3841 - Surgical and Medical Instruments and Apparatus |